Market Cap 202.90M
Revenue (ttm) 40,000.00
Net Income (ttm) -160.87M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -402,175.00%
Debt to Equity Ratio 0.00
Volume 319,600
Avg Vol 451,144
Day's Range N/A - N/A
Shares Out 46.33M
Stochastic %K 47%
Beta 2.81
Analysts Strong Sell
Price Target $27.70

Company Profile

4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. Its lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degene...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 505 2680
Address:
5858 Horton Street, Suite 455, Emeryville, United States
ReturnOfEsquire
ReturnOfEsquire Jul. 16 at 3:43 PM
$FDMT Try not to think about it...
0 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 16 at 3:20 PM
$FDMT Huge volume drop since the beginning of the month...no clue why.
1 · Reply
Emremumcu01
Emremumcu01 Jul. 15 at 3:49 PM
$FDMT sinking ship
1 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 15 at 1:58 PM
$FDMT Volume today...?
0 · Reply
Emremumcu01
Emremumcu01 Jul. 14 at 7:09 PM
$FDMT up down up down up down all day
1 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 14 at 6:19 PM
$FDMT Not too far off from green on the 30, 90 and 180-day charts.
0 · Reply
Emremumcu01
Emremumcu01 Jul. 11 at 7:55 PM
$FDMT this stock gives me trust issues .
0 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 11 at 2:49 PM
$FDMT I don't know the short interest, but with this volume, shorts could get stuck. That may have been what caused that rip to 5.
2 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 10 at 7:21 PM
$FDMT I predict a 4.45 close.
0 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 10 at 2:45 PM
$FDMT Up 11% so far.
1 · Reply
Latest News on FDMT
4DMT Announces New Employment Inducement Grants

Jul 11, 2025, 4:05 PM EDT - 5 days ago

4DMT Announces New Employment Inducement Grants


4DMT to Participate in Upcoming Investor Conferences

May 28, 2025, 8:00 AM EDT - 7 weeks ago

4DMT to Participate in Upcoming Investor Conferences


ReturnOfEsquire
ReturnOfEsquire Jul. 16 at 3:43 PM
$FDMT Try not to think about it...
0 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 16 at 3:20 PM
$FDMT Huge volume drop since the beginning of the month...no clue why.
1 · Reply
Emremumcu01
Emremumcu01 Jul. 15 at 3:49 PM
$FDMT sinking ship
1 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 15 at 1:58 PM
$FDMT Volume today...?
0 · Reply
Emremumcu01
Emremumcu01 Jul. 14 at 7:09 PM
$FDMT up down up down up down all day
1 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 14 at 6:19 PM
$FDMT Not too far off from green on the 30, 90 and 180-day charts.
0 · Reply
Emremumcu01
Emremumcu01 Jul. 11 at 7:55 PM
$FDMT this stock gives me trust issues .
0 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 11 at 2:49 PM
$FDMT I don't know the short interest, but with this volume, shorts could get stuck. That may have been what caused that rip to 5.
2 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 10 at 7:21 PM
$FDMT I predict a 4.45 close.
0 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 10 at 2:45 PM
$FDMT Up 11% so far.
1 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 10 at 2:32 PM
$FDMT Not even 25K shares traded in the first hour. If you really have some time to waste, watch L2. If I didn’t know better, I'd think the stock was halted.
1 · Reply
Emremumcu01
Emremumcu01 Jul. 10 at 12:16 PM
$FDMT I demand 5 $ today !
0 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 9 at 2:52 PM
$FDMT It's recovering on low volume. I think that means people aren't selling at these low prices. 3.20 was the last support. Then 3.70. Simple math and trends suggest the next support will be around 4.20. That's my very non-expert analysis.
0 · Reply
Emremumcu01
Emremumcu01 Jul. 8 at 4:31 PM
$FDMT nobody. Say. Anything .
0 · Reply
Florestan
Florestan Jul. 7 at 4:08 PM
$FDMT so far the bears have crushed. By 2029 when they go to market the existing therapies would have improved greatly and may match what FDMT can do. Even worse, the AAV vector cannot be redosed, and with durability not lasting at least years and years, the economic model can't work. This is game over imho.
1 · Reply
Emremumcu01
Emremumcu01 Jul. 7 at 3:36 PM
$FDMT another amazing day of owning FDMT
1 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 4 at 3:41 PM
$FDMT The bears are coming guys. That might be a good thing for the price and momentum. So far, they are 0-1.
0 · Reply
Florestan
Florestan Jul. 4 at 1:33 PM
$FDMT this is dead in the water after the durability data they presented. 43% had to have another injection within a year. This is not a one-and-done therapy and so will never command premium pricing even if it is more convenient. The annual cost of treatment in the SoC is 20k annually, the convenience of 1 shot a year versus 6 is probably worth another 10k premium, but that's it imo. Nobody would shell out more just for the convenience.
1 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 3 at 3:08 PM
$FDMT After that PR, this ticker should be up 10-20%. Rapid enrollment. Early data. Cash runway extension. The resignation of the CFO does not make that an overall negative PR...disappointing.
1 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 3 at 2:08 AM
$FDMT https://www.morningstar.com/news/globe-newswire/9488576/4dmt-announces-accelerated-4d-150-phase-3-development-in-wet-amd-and-streamlined-organization-to-drive-late-stage-execution
0 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 3 at 12:37 AM
$FDMT When this thing takes off, everyone will wonder why they never heard of this company.
1 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 2 at 9:54 PM
$FDMT With this ticker, that great PR won't move the needle...watch.
1 · Reply